医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Medidata to Participate in U.S. Trade Mission to Japan and South Korea, Supporting Stronger Economic Ties in Healthcare and Energy Sectors

2014年10月21日 PM09:30
このエントリーをはてなブックマークに追加


 

NEW YORK

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Bryan Spielman, Medidata’s executive vice president of strategy and corporate development, and Takeru Yamamoto, Medidata’s managing director of the Asia-Pacific region, will join U.S. Secretary of Commerce Penny Pritzker on her first trade mission to Asia since taking office in June 2013. The mission will focus on business development opportunities in the healthcare and energy sectors in Japan and South Korea, underscoring the U.S. administration’s ongoing efforts to strengthen commercial ties across Asia.

“The 20 American companies joining us on this trade mission are leaders and innovators in healthcare and energy, and they have the expertise and resources to serve as partners to Japan and Korea in these two critical sectors,” said U.S. Secretary of Commerce Penny Pritzker. “These companies share a desire to do more business in Japan and Korea, to develop new and deeper partnerships here, and to make investments in this market for the long-term. Throughout this trade mission to Japan and Korea, our American business leaders will help deepen and strengthen our commercial ties in the Asia-Pacific region, while also finding new markets for their goods and services.”

Along with representatives from other U.S.-based firms, including Abbott, Eli Lilly and Merck & Co, Spielman will participate in a program designed to connect U.S. healthcare and life science companies with those in Japan and Korea and stimulate collaborative business opportunities. His participation exemplifies Medidata’s commitment to enabling life science organizations in Japan and Korea—and all areas of the world—to transform their clinical trials through the Medidata Clinical Cloud™, the company’s platform of advanced technologies and data analytics.

“Our mission is to help life science organizations everywhere deliver safe, new medicines to patients as quickly as possible, so we’re proud to be working closely with a growing number of life science organizations in Japan and Korea,” Spielman said. “I’m looking forward to spending time in both countries, exploring how Medidata can continue to further support more companies with their drug development programs.”

Medidata’s managing director for the Asia-Pacific region, Takeru Yamamoto, added: “Regulatory authorities across the globe are progressively requiring electronic submission of data from clinical trials and, by 2016, it will be mandatory in Japan. As a global leader in clinical trial software solutions, Medidata has unmatched expertise and experience in electronic collection, management and submission of clinical study data. We are delighted that our solutions are helping an ever-increasing number of Japanese and Korean companies accelerate their clinical trials and bring their life-saving therapies to market globally.”

Connect with Medidata:

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

CONTACT

Medidata Solutions
Investors:
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media:
Nicole
Pariser, 212-659-1069
npariser@mdsol.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 亚马逊与美国国家安全委员会携手开展业界首创合作项目,以解决美国常见的工伤问题
  • Aragen Announce Multi-Year Partnership With FMC Corporation, Aims at Accelerating Agro-Chemical Pipeline
  • 片肺換気中の高酸素血症介在疾患の罹患率にORiを指針とする酸素需要評価が及ぼす影響についての新研究
  • セルトリオン、抗COVID-19モノクローナル抗体治療剤「Regdanvimab(CT-P59)」の グローバル第3相臨床試験結果を発表
  • 沃特世推出SELECT SERIES MRT多反射飞行时间质谱平台,树立高分辨质谱性能新标杆